Patent · US Active

Glucagon-like-peptide-2 (GLP-2) analogues

US9453064B2 · kind B2 · utility

16Cited by

25References

41Claims

0Family size

Assignee

Zealand Pharma A/S · DK

Inventors

Rasmus JUST · Copenhagen, DK
Kirsten Lindegaard Bovbjerg · Hørsholm, DK
Ditte Riber · Copenhagen, DK
Wayne Shaun Russell · Katrineholm, SE

Key dates

Filing date	May 3, 2013
Grant date	Sep 27, 2016
Priority date	—
Expiry date	May 3, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

GLP-2 analogs are disclosed which comprise one of more substitutions as compared to h[Gly2]GLP-2 and which may have the property of an altered GLP-1 activity, and their medical use. The analogs are particularly useful for the prophylaxis, treatment or ameliorating of the gastro-intestinal associated side effects of diabetes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.